COUNTERFEIT DRUGS REMAIN A SUPPLY CHAIN RISK IN EMERGING MARKETS
Counterfeit drugs gained notoriety in the mid-1980s with the illegal reproduction of prescription products to treat baldness and obesity. More than 25 years later, falsified drugs are still a persistent threat—with products ranging from those in high demand to those that are intended to save lives.
| Have Your Say Rate this feature and give us your feedback in the comments section below |
Insights from the world’s foremost thought leaders delivered to your inbox.
2022-09-27
11:00 AM - 12:00 PM EST
Find out how Thermo Fisher Scientific and ParkourSC are leveraging modern supply chain technologies...
2022-09-15
10:00 AM - 11:00 AM EST
Watch this webinar to improve quality, increase visibility and traceability, and reduce risk by digi...
2022-04-14
12:00 PM - 01:00 PM CDT
Join this webinar with ParkourSC to learn how digital twin technology can improve the visibility of...
